William Haseltine

Dr. William Haseltine is an internationally renowned scientist and medical researcher. Throughout his storied career, he has developed strategies for treating HIV/AIDS, done groundbreaking work on cancer, and pioneered the use of the human genome to identify and treat diseases. For his relentless dedication to ensuring advancements in medical technology translate to improved health outcomes around the world, he has been named one of TIME’s 25 Most Influential Global Business Executives and one of Scientific American’s 100 Most Influential Leaders in Biotechnology.

‍

Dr. Haseltine is a prolific author who has penned over 250 academic articles and more than a dozen books covering topics including aging, treatments for specific diseases, and the successes of different healthcare systems around the globe. His most recent publication is My Lifelong Fight Against Disease: From Polio and AIDS to COVID-19, an autobiography documenting Haseltine’s contributions to some of the most brilliant medical breakthroughs in modern history. Dr. Sanjay Gupta said Haseltine’s achievement-studded journey through global health leaves readers “inspired to make an impact on the world.” Dr. Haseltine is also a frequent contributor to Forbes where in each article he focuses on a specific healthcare challenge and offers best practices and innovative solutions to overcome it. 

‍

Haseltine is the founder of more than a dozen biotechnology companies, including Human Genome Sciences, which pioneered the application of genomics to drug discovery and coined the term regenerative medicine. With more than 50 patents to his name, eight different pharmaceutical products from companies he has founded are currently approved by U.S. and international regulatory agencies. He is founder, chair, and CEO of ACCESS Health International, a not-for-profit organization dedicated to improving access to high quality affordable healthcare worldwide. The foundation is active in the United States, India, and Southeast Asia. 

‍

A former professor, Dr. Haseltine has educated an entire generation of doctors at Harvard Medical School and the Harvard School of Public Health. There he founded the Division of Biochemical Pharmacology and the Division of Human Retrovirology dedicated to cancer and HIV/AIDS research.